|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/538 | |
| A61K 45/06 | |||
| A61P 1/16 |
| (11) | Number of the document | 3518936 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17784023.8 |
| Date of filing the European patent application | 2017-09-26 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2017/034654 |
| Date | 2017-09-26 |
| (87) | Number | WO 2018/062134 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662400200 P | 2016-09-27 | US |
| (72) |
COOREMAN, Michael P., US
KIKKAWA, Kohei, JP
|
| (73) |
Mitsubishi Tanabe Pharma Corporation,
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505,
JP
|
| (54) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE |